Histotripsy can help release HER2 from cancer tumor cells

Scientists discover how the therapy could be used to stimulate the immune system against cancer

4:30 PM

Author | Kelly Malcom

cancer cell drawing in blue some yellow off white background
Jacob Dwyer, Justine Ross, Michigan Medicine

A revolutionary new therapy, called histotripsy, was created at the University of Michigan and uses soundwaves to destroy liver tumors. 

It was approved for clinical use by FDA in 2023. 

The scientists behind the development of histotripsy are actively investigating its use with other types of tumors including breast cancer.

A recent study in the journal Cancers demonstrates how histotripsy could stimulate the immune system to destroy a cancer through the release of tumor antigens.

Histotripsy can trigger the “abscopal effect”, wherein the ablation of tumors in one area leads to an immune response that shrink tumors in other sites of the body.

The researchers hypothesized that this effect is caused by the activation of the immune system against cancer-related proteins that are released from tumor cells by sonic disruption. 

They tested this using a mouse model of breast cancer where one tumor was disrupted with histotripsy.

They found that treated cancers released a protein called HER2, a well-known tumor antigen found in some breast cancers.

Importantly, the higher the histotripsy dose, the more HER2 released from the tumor cells.

This supports the use of histotripsy immunotherapy against HER2 positive cancers.

Authors: Shengzhuang Tang, Reliza McGinnis, Zhengyi Cao, James R. Baker, Jr., Zhen Xu and Suhe Wang

Paper cited: “Ultrasound-Guided Histotripsy Triggers the Release of Tumor-Associated Antigens from Breast Cancers,” Cancers. DOI: 10.3390/cancers17020183

Disclosure: U-M retains a financial interest in HistoSonics, as do a number of researchers who were involved in this project and who helped develop the technology licensed to HistoSonics, including Xu, who is a company founder, stockholder and consultant. Each stands to benefit financially from the success of the platform. The company was formed with support from Innovation Partnerships, U-M’s central hub for research commercialization. 


More Articles About:

Cancer (Oncology) All Research Topics Histotripsy
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

University of Michigan block M logo

Zhen Xu

Professor

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Alarm clock sitting on a white dinner plate with blue and yellow flowers on the rim and a fork and knife positioned on either side of the plate.
Health Lab

Intermittent fasting can reverse diabetes in mice, study finds

Study shows intermittent fasting and meal timing can help reverse type 2 diabetes by resting pancreatic beta cells
Mother sits on a couch with a laptop on her lap while an elementary school age boy sits next to her playing on a tablet device.
Health Lab

New questionnaire aims to improve understanding of demand avoidance in children, teens

Pathological demand avoidance is a pattern of intense distress and avoidance of demands in children. A new questionnaire from University of Michigan researchers creates a structured way to assess these behaviors.
Blue round cells in three pictures showing how they change under stress.
Health Lab

Timing is of the essence for RNA during stress

Key determiners of which RNA can be read to make proteins is time. Previous thinking was that a cell under threat would quickly make these RNAs in the nucleus and immediately push them into the cytoplasm.
Blue and yellow illustration of DNA helix
Health Lab

New anti-cancer strategy shows promise in preclinical studies

New cancer therapeutic strategy rewires protein interactions to improve efficacy and reduce potential side effects.
Closeup of newborn baby, whose head is held by a blue medical gloved hand. Blue gloved hand also holds a stethoscope to baby's chest.
Health Lab

More babies with hypoplastic left heart syndrome surviving critical period between surgeries

Collaborative effort helped sustain improvements in survival for babies born with hypoplastic left heart syndrome (HLHS), a serious congenital heart condition that requires multiple surgeries.
Rachel Upjohn Building groundbreaking ceremony
News Release

How U-M helped bring depression out of the darkness

The history of the founding of the Eisenberg Family Depression Center at the University of Michigan, the nation's first center focused on research, community outreach and stigma reduction in depression and bipolar disorder.